{
    "eid": "2-s2.0-85082762579",
    "title": "A case of GABRA5-related developmental and epileptic encephalopathy with response to a combination of antiepileptic drugs and a GABAering agent",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Developmental Neuroscience",
            "@code": "2806",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Developmental delay",
        "Epileptic encephalopathy",
        "GABAA receptor",
        "GABRA5"
    ],
    "authors": [
        "Ponghatai Boonsimma",
        "Sirorat Suwannachote",
        "Chureerat Phokaew",
        "Chupong Ittiwut",
        "Kanya Suphapeetiporn",
        "Vorasuk Shotelersuk"
    ],
    "citedby-count": 1,
    "ref-count": 9,
    "ref-list": [
        "Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy",
        "Deleterious rare variants reveal risk for loss of GABAA receptor function in patients with genetic epilepsy and in the general population",
        "Mutations in GABAA receptor subunits associated with genetic epilepsies",
        "De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy",
        "Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies",
        "Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study",
        "Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy",
        "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology",
        "High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60010778",
            "affilname": "Queen Sirikit National Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010778",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thailand Research Fund"
    ]
}